Dimensional Fund Advisors
ORMP icon

Dimensional Fund Advisors’s Oramed Pharmaceuticals ORMP Stock Holding History

Dimensional Fund Advisors’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$538K Buy
158,209
+7,738
+5% +$26.3K ﹤0.01% 2931
2025
Q4 		$429K Buy
150,471
+2,984
+2% +$7.7K ﹤0.01% 2993
2025
Q3 		$389K Sell
147,487
-19,412
-12% -$42.9K ﹤0.01% 3033
2025
Q2 		$376K Buy
166,899
+25,818
+18% +$56.9K ﹤0.01% 3039
2025
Q1 		$302K Buy
141,081
+22,086
+19% +$51K ﹤0.01% 3078
2024
Q4 		$288K Buy
118,995
+70,190
+144% +$167K ﹤0.01% 3120
2024
Q3 		$119K Buy
48,805
+17,335
+55% +$42.3K ﹤0.01% 3225
2024
Q2 		$80.9K Buy
31,470
+10,774
+52% +$25.6K ﹤0.01% 3272
2024
Q1 		$60.4K Buy
+20,696
New +$57.9K ﹤0.01% 3320
2023
Q4 		– Sell
-27,285
Closed -$71.2K – 3444
2023
Q3 		$71.2K Buy
+27,285
New +$85.9K ﹤0.01% 3351

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $5.76B AUM 24.57% 1-Year Est. Return

Dimensional Fund Advisors's ORMP Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Oramed Pharmaceuticals (ORMP) stake by 5.1% in Q1 2026, buying an estimated $26.3K and bringing the position to 158,209 shares worth $538K. The position accounts for ﹤0.01% of the portfolio, ranked #2931.

Dimensional Fund Advisors first reported a position in ORMP in Q3 2023 and has held it in 10 quarters since. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Dimensional Fund Advisors held 158,209 shares of Oramed Pharmaceuticals worth $538K as of Q1 2026.
  • Dimensional Fund Advisors bought 7,738 Oramed Pharmaceuticals shares in Q1 2026, an estimated $26.3K.
  • Oramed Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2931 holding.
  • Dimensional Fund Advisors first reported a position in Oramed Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.